RCT: Mitapivat vs. placebo for Pyruvate Kinase Deficiency.
18 Apr, 2022 | 10:13h | UTCMitapivat versus Placebo for Pyruvate Kinase Deficiency – New England Journal of Medicine
Mitapivat versus Placebo for Pyruvate Kinase Deficiency – New England Journal of Medicine